| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.027 | 0.9 |